Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedSep 18, 2025
DataAggregated Company Financials
Companies5
  • 7D0.2%
  • 3M23.6%
  • 1Y-17.4%
  • YTD-2.4%

The Biotech industry has stayed flat over the last week. Unfortunately though, the industry is down 17% over the past 12 months. As for the next few years, earnings are forecast to decline by 9.6% per annum.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 19 Sep 2025DKK 158.0bDKK 38.6bDKK 16.7b12.6x9.5x4.1x
Sun, 17 Aug 2025DKK 137.3bDKK 38.6bDKK 16.7b10.5x8.2x3.6x
Tue, 15 Jul 2025DKK 125.0bDKK 27.0bDKK 7.3b11.1x17x4.6x
Thu, 12 Jun 2025DKK 141.1bDKK 27.3bDKK 7.5b11.7x18.9x5.2x
Sat, 10 May 2025DKK 125.9bDKK 28.0bDKK 7.9b10.1x15.9x4.5x
Mon, 07 Apr 2025DKK 121.4bDKK 27.3bDKK 7.7b10.7x15.8x4.4x
Wed, 05 Mar 2025DKK 157.8bDKK 27.7bDKK 7.8b12.3x20.2x5.7x
Fri, 31 Jan 2025DKK 155.9bDKK 26.0bDKK 4.7b16.5x33.2x6x
Sun, 29 Dec 2024DKK 163.5bDKK 26.0bDKK 4.7b17x34.8x6.3x
Tue, 26 Nov 2024DKK 162.4bDKK 26.0bDKK 4.7b16.9x34.6x6.2x
Thu, 24 Oct 2024DKK 177.9bDKK 25.5bDKK 5.5b21.5x32.5x7x
Sat, 21 Sep 2024DKK 191.9bDKK 25.5bDKK 5.5b23.3x35.1x7.5x
Mon, 19 Aug 2024DKK 206.7bDKK 26.1bDKK 5.7b21.7x36x7.9x
Wed, 17 Jul 2024DKK 197.2bDKK 24.8bDKK 5.6b17.8x35x8x
Fri, 14 Jun 2024DKK 170.7bDKK 24.8bDKK 5.6b17.3x30.3x6.9x
Sun, 12 May 2024DKK 183.7bDKK 24.8bDKK 5.7b18.3x32.4x7.4x
Tue, 09 Apr 2024DKK 186.6bDKK 23.9bDKK 5.0b19.3x37x7.8x
Thu, 07 Mar 2024DKK 184.6bDKK 22.8bDKK 4.3b23.4x43.2x8.1x
Sat, 03 Feb 2024DKK 166.2bDKK 23.3bDKK 4.2b22.8x39.9x7.1x
Mon, 01 Jan 2024DKK 177.2bDKK 23.3bDKK 4.2b25.9x42.6x7.6x
Wed, 29 Nov 2023DKK 166.8bDKK 23.3bDKK 4.2b24.4x40.1x7.2x
Fri, 27 Oct 2023DKK 160.8bDKK 22.0bDKK 4.7b18.6x34x7.3x
Sun, 24 Sep 2023DKK 196.1bDKK 22.0bDKK 4.7b23x41.4x8.9x
Tue, 22 Aug 2023DKK 187.2bDKK 20.6bDKK 3.9b35.3x47.4x9.1x
Thu, 20 Jul 2023DKK 206.5bDKK 19.5bDKK 4.4b41.3x46.9x10.6x
Sat, 17 Jun 2023DKK 208.1bDKK 19.5bDKK 4.4b44x47.2x10.6x
Mon, 15 May 2023DKK 218.9bDKK 17.9bDKK 4.0b33.9x54.8x12.2x
Wed, 12 Apr 2023DKK 201.8bDKK 17.9bDKK 3.5b31.4x57x11.3x
Fri, 10 Mar 2023DKK 192.7bDKK 17.9bDKK 3.5b29.7x54.3x10.8x
Sun, 05 Feb 2023DKK 201.8bDKK 14.7bDKK 3.3b30.8x61.7x13.7x
Tue, 03 Jan 2023DKK 223.2bDKK 14.7bDKK 3.3b34.7x68.2x15.1x
Thu, 01 Dec 2022DKK 241.4bDKK 14.7bDKK 3.3b37.7x73.8x16.4x
Sat, 29 Oct 2022DKK 216.8bDKK 12.4bDKK 1.5b47.8x142.7x17.5x
Mon, 26 Sep 2022DKK 181.0bDKK 12.4bDKK 1.5b40.2x121.6x14.6x
Price to Earnings Ratio

121.6x


Total Market Cap: DKK 181.0bTotal Earnings: DKK 1.5bTotal Revenue: DKK 12.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 42.5x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 9.5x which is lower than its 3-year average PE of 42.6x.
  • The 3-year average PS ratio of 8.6x is higher than the industry's current PS ratio of 4.1x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 124% per year over the last three years.
  • Revenues for these companies have grown 46% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market1.30%
Healthcare3.66%
Biotech0.17%
Biotech0.17%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ZEAL Zealand PharmaDKK 465.708.3%
+DKK 2.5b		-49.3%PE4.9x
BIOPOR BioPortoDKK 1.310.8%
+DKK 4.5m		-31.8%PS16.6x
STRAP Strategic PartnersDKK 956.000.4%
+DKK 166.8k		9.3%PB2.2x

Latest News

STRAP
DKK 956.00
Strategic Partners
7D
0.4%
1Y
9.3%
GMAB
DKK 1,776.50
Genmab
7D
-2.5%
1Y
0.7%
ZEAL
DKK 465.70
Zealand Pharma
7D
8.3%
1Y
-49.3%

Clinical Catalysts And Roche Alliance Will Advance Obesity Amid Risks

Analysts maintain a positive long-term outlook on Zealand Pharma despite near-term competitive and pipeline risks, leading to a modest consensus price target reduction from DKK835.47 to DKK818.80 as updated risk assessments are incorporated. Analyst Commentary Bullish analysts cite attractive entry points at current share levels, suggesting the stock is undervalued given long-term growth potential.
BAVA
DKK 230.40
Bavarian Nordic
7D
-1.8%
1Y
-6.4%

VIMKUNYA Launch Will Open Markets, But Approval Delays Could Impact Revenues

Despite a deterioration in consensus revenue growth forecasts, a modest improvement in net profit margin has supported a slight increase in Bavarian Nordic's fair value, with the target price rising from DKK234.50 to DKK244.00. What's in the News Nordic Capital and Permira have proposed to acquire Bavarian Nordic for DKK 18.1 billion (DKK 233 per share), a 21% premium to the prior closing price; board and management have agreed to tender their shares, and a delisting is planned upon completion, subject to customary conditions.
BIOPOR
DKK 1.31
BioPorto
7D
0.8%
1Y
-31.8%